Galiximab
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 20:57, 23 December 2019 (Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:57, 23 December 2019 by InternetArchiveBot (talk | contribs) (Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0)
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric (primate/human) |
Target | CD80 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG |
|
![]() ![]() |
Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009[update], it is undergoing Phase III clinical trials.[1] The drug is a chimeric antibody from Macaca irus and Homo sapiens.[2]
References
- ^ "Biogen Idec: Pipeline". Archived from the original on 2008-05-17. Retrieved 2009-09-24.
- ^ WHO Drug Information
External links
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
| ||||||||||||||
Unsorted |
|
![]() | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
![]() | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Galiximab&oldid=932154958"
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- Articles containing potentially dated statements from September 2009
- All articles containing potentially dated statements
- All stub articles